Seebri Breezhaler

Seebri Breezhaler Description

glycopyrronium bromide

Manufacturer:

Novartis

Distributor:

Zuellig Pharma

Marketer:

A. Menarini
Full Prescribing Info
Description
Each capsule contains 63 micrograms of glycopyrronium bromide equivalent to 50 micrograms of glycopyrronium.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 55 micrograms of glycopyrronium bromide equivalent to 44 micrograms of glycopyrronium.
Excipient(s) with known effect: Each capsule contains 23.6 mg lactose (as monohydrate).
Excipients/Inactive Ingredients: Capsule fill: Lactose monohydrate, magnesium stearate.
Capsule shell:
Hypromellose, Purified water, Carrageenan, Potassium chloride, FDC Yellow 6 (110 Sunset Yellow FCF).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in